Real-life evaluation of histologic scores for Ulcerative Colitis in remission

被引:9
|
作者
Arkteg, Christian Borde [1 ]
Sorbye, Sveinung Wergeland [2 ]
Riis, Lene Buhl [3 ,4 ]
Dalen, Stig Manfred [2 ]
Florholmen, Jon [1 ,5 ]
Goll, Rasmus [1 ,5 ]
机构
[1] UiT Arctic Univ Norway, Inst Clin Med, Res Grp Gastroenterol Nutr, Tromso, Norway
[2] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway
[3] Herlev Gentofte Hosp, Dept Pathol, Herlev, Denmark
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Univ Hosp North Norway, Dept Gastroenterol, Div Internal Med, Tromso, Norway
来源
PLOS ONE | 2021年 / 16卷 / 03期
关键词
RELAPSE; INFLAMMATION; PARAMETERS; PREDICTORS; INFLIXIMAB; AGREEMENT; MARKERS; RISK;
D O I
10.1371/journal.pone.0248224
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Histological evaluation of ulcerative colitis (UC) patients has been debated ever since the first description of the disease and its role in follow-up has never been fully established. Recent evidence suggests an added benefit in accuracy when evaluating if the patient is in remission. Unfortunately, there are several different histological indices, and it is difficult to compare outcomes where different scores are applied. Histopathological evaluation is prone to subjective biases, despite the use of indices. In addition, these indices are developed by expert IBD pathologist, but applied at large, by general pathologist. Therefore, we evaluated the three most applied histological indices for UC on samples from patients in remission to compare test qualities and estimate their usefulness to identify remission by both general and GI specialized pathologist. Method Mucosal biopsies from 41 UC patients in clinical and endoscopic remission were collected as part of a larger study on UC. Three pathologists blinded to the patients' clinical status evaluated them using Geboes score (GS), Nancy Index (NI) and Robarts Histopathological Index (RHI). We calculated the agreement between the pathologists using Inter-class correlation (ICC) and visualized it with ICC-plots and Bland-Altman plots. Association between clinical factors and histological category were analysed by Fisher's exact test. Results The ICC value for GS, RHI and NI were 0.85, 0.73 and 0.70 respectively. The limits of agreement were +/- 6.1, +/- 4.0 and +/- 1.4, for GS, RHI and NI, respectively. Mayo endoscopic subgrade and UC clinical score did not show association with any histological scores. Despite clinical and endoscopic remission 7-35% of the patients displayed histological inflammation on a level classified as active disease, depending on the index and cut-off. Conclusion A substantial amount of UC patients in clinical and endoscopic remission display inflammation on a histological level, but the ability to classify these patients accurately and consistently could be improved.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitis
    Ivanovski, T. Knezevic
    Usaj, S. Knezevic
    Svorcan, P.
    Protic, M. Nedeljkovic
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S248 - S248
  • [32] Faecal Calprotectin as a predictor of endoscopic and histologic remission in patients with Ulcerative Colitis
    Hahn, G. Drugg
    Flores, C.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    Bessissow, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I843 - I844
  • [33] Maintenance of deep remission in patients with ulcerative colitis treated with thiopurines after withdrawal of the drug: Perspective real-life experience of a single centre
    Mazza, M.
    Pratico, C.
    Salice, M.
    Calafiore, A.
    Calandrini, L.
    Calabrese, C.
    Campieri, M.
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S456 - S456
  • [34] Effectiveness and safety of golimumab in inducing remission in outpatient ulcerative colitis patients: a first 'real-life' experience in primary gastroenterology centres in Italy
    Tursi, A.
    Allegretta, L.
    Della Valle, N.
    Hadad, Y.
    Penna, A.
    Pranzo, G.
    Ricciardelli, C.
    Paiano, P.
    Picchio, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S385 - S385
  • [35] Outcomes of endoscopic and histologic remission in ulcerative colitis under advanced therapy
    Rodrigues, I.
    Bronze, S.
    Fernandes, S.
    Saraiva, S.
    Bernardo, S.
    Goncalves, A. R.
    Moura Santos, P.
    Valente, A.
    Araujo Correia, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I601 - I601
  • [36] Faecal calprotectin in assessing endoscopic and histologic remission in patients with ulcerative colitis
    Mak, W. Y.
    Buisson, A.
    Andersen, M. J., Jr.
    Lei, D.
    Pekow, J.
    Cohen, R. D.
    Kahn, S. A.
    Pereira, B.
    Rubin, D. T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S199 - S200
  • [37] MAINTENANCE OF DEEP REMISSION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH THIOPURINES AFTER WITHDRAWAL OF THE DRUG: PERSPECTIVE REAL-LIFE EXPERIENCE OF A SINGLE CENTER
    Mazza, M.
    Pratico, C.
    Salice, M.
    Calafiore, A.
    Sgambato, D.
    Spuri, G.
    Calandrini, L.
    Campieri, M.
    Rizzello, F.
    Gionchetti, P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 : E210 - E210
  • [38] Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study
    Angelison, Leif
    Almer, Sven
    Davidsdottir, Loa
    Hammarlund, Per
    Lindgren, Stefan
    Hindorf, Ulf
    Marsal, Jan
    Hertervig, Erik
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 154 - 162
  • [39] Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
    Fabrizio Bossa
    Giuseppe Biscaglia
    Maria Rosa Valvano
    Giuseppe Costantino
    Angelo Lauria
    Rocco Clemente
    Concetta Ferracane
    Endrit Shahini
    Marco Mendolaro
    Laurino Grossi
    Silvia Mazzuoli
    Antonio Rispo
    Giuseppe Pranzo
    Ladislava Sebkova
    Antonio Tursi
    Agnese Miranda
    Marta Patturelli
    Rocco Spagnuolo
    Cristina Ricciardelli
    Caterina Sgarro
    Pietro Paese
    Gaetano Inserra
    Alessandro Azzarone
    Olga Nardone
    Walter Fries
    Nello Buccianti
    Antonino Carlo Privitera
    Maria Beatrice Principi
    Maria Cappello
    Francesco William Guglielmi
    Marco Romano
    Gabriele Riegler
    Libera Fanigliulo
    Raffaele Melina
    Angelo Andriulli
    [J]. Digestive Diseases and Sciences, 2020, 65 : 1767 - 1776
  • [40] Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients
    Iborra, M.
    Garcia-Morales, N.
    Rubio, S.
    Nantes Castillejo, O.
    Bertoletti, F.
    Garcia-Planella, E.
    Calvo, M.
    Vera, I.
    Taxonera, C.
    Alba, C.
    Bosca-Watts, M.
    Marti-Aguado, D.
    Ballester Ferrer, M. P.
    Sierra, M.
    Cano-Sanz, N.
    Mancenido, N.
    Pajares-Villarroya, R.
    Beltran, B.
    Canada, A.
    Nos, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S393 - S394